Developing methods to prevent cancer using genomic data
Statistical Methods for Precision Prevention
This study is exploring new ways to use genetic information to help prevent cancer by understanding what causes it, so that we can better identify who is at risk and create personalized prevention plans, especially by looking closely at tumor characteristics and their surroundings.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11025722 on NIH RePORTER |
What this research studies
This research focuses on creating advanced statistical and computational methods to utilize genomic data for cancer prevention. By analyzing molecular events and understanding the causes of cancer, the project aims to improve risk assessment and develop targeted prevention strategies. The study will leverage cutting-edge technologies, such as spatial omics, to gain insights into tumor characteristics and their environments, which is crucial for distinguishing between aggressive and less harmful tumors. The researchers will address challenges in data analysis to ensure accurate integration of individual risk factors with genomic features.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for developing cancer, particularly those with genetic predispositions or family histories of the disease.
Not a fit: Patients with no genetic risk factors for cancer or those already diagnosed with advanced cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer prevention strategies tailored to individual risk profiles.
How similar studies have performed: Previous research has shown promise in using genomic data for cancer prevention, indicating that this approach could lead to significant advancements in the field.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Hsu, Li — Fred Hutchinson Cancer Center
- Study coordinator: Hsu, Li
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.